American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update
The DOI matches its Crossref record; 355 of the 356 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the standardized production of clinical practice guidelines (CPGs). Methods: Recommendations are based on diligent reviews of the clinical evidence with transparent incorporation of subjective factors, according to established AACE/ACE guidelines for guidelines protocols. Results: The Executive Summary of this 2020 updated guideline contains 52 recommendations: 21 Grade A (40%), 24 Grade B (46%), 7 Grade C (14%), and no Grade D (0%). These detailed, evidence-based recommendations allow for nuance-based clinical decision-making that addresses multiple aspects of real-world care of patients. The evidence base presented in the subsequent Appendix provides relevant supporting information for the Executive Summary recommendations. This update contains 368 citations: 123 (33.5%) evidence level (EL) 1 (highest), 132 (36%) EL 2 (intermediate), 20 (5.5%) EL 3 (weak), and 93 (25%) EL 4 (lowest). New or updated topics in this CPG include: clarification of the diagnosis of osteoporosis, stratification of the patient according to high-risk and very-high-risk features, a new dual-action therapy option, and transitions from therapeutic options. Conclusion: This guideline is a practical tool for endocrinologists, physicians in general, regulator…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical trials have demonstrated A1C lowering of 0.9% to 1.2% over 6 to 12 months irrespective of weight loss.792–794”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [792]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538 · cited 4×
“Adults who are vitamin D insufficient or deficient (serum 25[OH]D 20 to 29 or <20 ng/mL, respectively) may be treated with 5,000 IU vitamin D3 daily for 8 to 12 weeks to achieve a 25(OH)D blood level >30 ng/mL (93,96).”
InfluentialSelf-citationRisk Factors for Falls among Elderly Persons Living in the Community
Tinetti, M. E., Speechley, M., & Ginter, S. F. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192604 · Cited by 6,509 · cited 1×
“Approximately one-third of people aged 65 years or older and roughly half of those aged 80 years or older fall each year (172,173).”
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602 · cited 4×
“Teriparatide (Forteo) (194, 306) Yes Yes No effect demonstrateda”
InfluentialCharles, C., Gafni, A., & Whelan, T. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00221-3 · Cited by 4,137 · cited 1×
“This is the first step toward shared decision-making (358-360), a process by which a plan of management is developed with active participation of the patient.”
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026 · cited 2×
“Other groups recommend that 25(OH)D values ≥20 ng/mL be considered adequate (109,110).”
Interventions for preventing falls in older people living in the community
Gillespie, L. D., Robertson, M. C., Gillespie, W. J., Sherrington, C., Gates, S., Clemson, L., & Lamb, S. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007146.pub3 · Cited by 3,966
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849 · cited 4×
“Despite these significant costs, less than 1 in 4 women aged 67 years or older with an osteoporosis-related fracture gets their bone density measured or begins osteoporosis treatment (7).”
Influential
Research works printed but not linked: 7
- Szulc, 2018, Use of CTX-I and PINP as bone turnover markers: Nationall Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability, Ann Biol Clin (Paris)., 76, 373
- 2008, J Rheumatol, 35, 488
- Wysowski, 2005, Alendronate and risedronate: reports of severe bone, joint, and muscle pain, Arch Intern Med., 165, 346
- Lewiecki, 2002, How common is loss of bone mineral density in elderly clinical practice patients receiving oral bisphosphonate therapy for osteoporosis, J Bone Miner Res., 17, S367
- Hochberg, 1999, Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group, Arthritis Rheum., 42, 1246, 10.1002/1529-0131(199906)42:6<1246::aid-anr22>3.0.co;2-u · DOI · Paper page
- Cummings, 2018, Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its extension, J Bone Miner Res., 33, 190, 10.1002/jbmr.3337 · DOI · Paper page
- Radonich, 2006, Community Environmental Monitoring Program 25th Anniversary Annual Workshop
Cited by
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
“Referral to a metabolic bone specialist may be appropriate [51].”
BackgroundSelf-citationPrevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study
Wang, L., Yu, W., Yin, X., Cui, L., Tang, S., Jiang, N., Cui, L., Zhao, N., Lin, Q., Chen, L., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.21106 · Cited by 573
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationShen, Y., Huang, X., Wu, J., Lin, X., Zhou, X., Zhu, Z., Pan, X., Xu, J., Qiao, J., Zhang, T., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.882241 · Cited by 448
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 338
Metadata
- Authors
- Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., Pessah-Pollack, R., McClung, M., Wimalawansa, S. J., & Watts, N. B.
- Affiliations
- Loyola University Medical Center (US)
- Houston Methodist (US)
- University of Wisconsin–Madison (US)
- Cincinnati VA Medical Center (US)
- Harvard University (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of California, San Francisco (US)
- Mayo Clinic (US)
- University of Vermont Medical Center (US)
- University of New Mexico Health Sciences Center (US)
- Australian Catholic University (AU)
- Emory University (US)
- Mercy Health (US)
- Corresponding author
- Camacho, Pauline M.
- ORCID
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 26
- Issue
- Suppl 1
- Pages
- 1-46
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W4211141844
- Cited by
- 1,182
- References
- 356
- Citations by year
- 2026: 195 · 2025: 228 · 2024: 248 · 2023: 193 · 2022: 182 · 2021: 110 · 2020: 20
- FWCI
- 127.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- postmenopausal osteoporosis, osteoporosis diagnosis, osteoporosis treatment, bone mineral density, fracture risk assessment, menopause
- MeSH terms
- Endocrinologists, Aged, Female, Humans, Middle Aged, United States, Absorptiometry, Photon, Bone Density, Osteoporosis, Postmenopausal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. https://app.cochat.ai/papers/10.4158/gl-2020-0524suppl
- The paper
- Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., Pessah-Pollack, R., McClung, M., Wimalawansa, S. J., & Watts, N. B. (2020). American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocrine Practice. https://doi.org/10.4158/gl-2020-0524suppl
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.